Preferred Reporting Items for
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
10
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
9
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
13
Compliance of systematic reviews in veterinary journals with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) literature search reporting guidelines
7
Preferred Reporting Items for Overviews of Reviews (PRIOR): a protocol for development of a reporting guideline for overviews of reviews of healthcare interventions
9
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement
7
Preferred reporting items for studies mapping onto preference based outcome measures : the MAPS statement
9
Preferred reporting items for studies mapping onto preference based outcome measures : the MAPS statement
8
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 : Elaboration and explanation
26
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
14
Jurors’ and judges’ evaluation of defendants with autism and the impact on sentencing : a systematic Preferred Reporting Items for Systematic Reviews and Meta analyses (PRISMA) review of autism spectrum disorder in the courtroom
21
Objective. To determine the efficacy of the SSC using data from randomised controlled trials (RCTs). Methods. This meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was
6
Action Items. Discussion Items. Report Items MCLS Director Patricia Uttaro reporting
Sample Letter For Reporting Lost Items
17
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
17
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality.
18
Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone
20
Reporting Form ARF Securitisation Supplementary Items Instruction Guide
13
Perceptions of Auditors in Malaysia on the Important Items of Internet Financial Reporting
13
Protocol for the development of the STrengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline : checklist of items for reporting pharmacogenetic studies
5